Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
The Journal of Surgical Research|June 17, 2018
A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitroAdele P Williams, Alicia M Waters, Jerry E Stewart, et al.Journal of Pediatric Surgery|November 5, 2018
Corruption of neuroblastoma patient derived xenografts with human T cell lymphomaAdele P Williams, Jerry E Stewart, Laura L Stafman, et al.Scientific Reports|May 4, 2018
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived XenograftsEvan F Garner, Adele P Williams, Laura L Stafman, et al.Journal of Pediatric Surgery|March 23, 2019
The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survivalLaura L Stafman, Mary G Waldrop, Adele P Williams, et al.Oncotarget|June 2, 2018
Targeting PIM kinase as a therapeutic strategy in human hepatoblastomaLaura L Stafman, Smitha Mruthyunjayappa, Alicia M Waters, et al.Cancer Gene Therapy|April 17, 2021
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cellsRaoud Marayati, Laura L Stafman, Adele P Williams, et al.Journal of Pediatric Surgery|March 12, 2023
The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on HepatoblastomaLaura V Bownes, Janet R Julson, Colin H Quinn, et al.Translational Oncology|July 31, 2019
UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line XenograftsAdele P Williams, Evan F Garner, Laura L Stafman, et al.Plos One|March 10, 2021
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growthLaura V Bownes, Adele P Williams, Raoud Marayati, et al.The Journal of Biological Chemistry|October 17, 2024
PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastomaNazia Nazam, Michael H Erwin, Janet R Julson, et al.Pageof 3